We are live on ! Find out more
VLC

Van Leeuwen & Company Portfolio holdings

AUM $197M
1-Year Est. Return 44.16%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+44.16%
3 Year Est. Return
+75.42%
5 Year Est. Return
+199.79%
10 Year Est. Return
AUM
$106M
AUM Growth
-$5.41M
Cap. Flow
-$5.53M
Cap. Flow %
-5.21%
Top 10 Hldgs %
35.12%
Holding
83
New
8
Increased
21
Reduced
38
Closed
11

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.88M
2
CSCO icon
Cisco
CSCO
+$1.74M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.57M
4
DRI icon
Darden Restaurants
DRI
+$1.57M
5
ROST icon
Ross Stores
ROST
+$1.36M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.13%
2 Technology 13.29%
3 Financials 12.94%
4 Healthcare 9.51%
5 Communication Services 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRI icon
76
Darden Restaurants
DRI
$23.9B
-12,920
Closed -$1.57M
KMI icon
77
Kinder Morgan
KMI
$69.4B
-38,178
Closed -$797K
LEN icon
78
Lennar Class A
LEN
$20.5B
-17,882
Closed -$839K
META icon
79
Meta Platforms (Facebook)
META
$1.5T
-3,781
Closed -$730K
PFE icon
80
Pfizer
PFE
$148B
-45,815
Closed -$1.88M
PGR icon
81
Progressive
PGR
$125B
-11,067
Closed -$885K
W icon
82
Wayfair
W
$14.4B
-1,500
Closed -$219K
XYZ
83
Block Inc
XYZ
$47.2B
-4,560
Closed -$331K

Similar funds

Van Leeuwen & Company's Q3 2019 Portfolio in Review

As of Q3 2019, Van Leeuwen & Company held 83 positions worth $106M, down 4.9% from $111M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Van Leeuwen & Company withdrew a net $5.53M in Q3 2019, closing 11 positions and reducing 38 holdings. Its most notable exit was Pfizer, an estimated $1.88M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

Against the trend, Van Leeuwen & Company opened a new position in El Paso Energy Capital Trust I worth $1.54M.

  • Van Leeuwen & Company's largest Q3 2019 buy was El Paso Energy Capital Trust I: 74,738 shares worth $1.54M.
  • Van Leeuwen & Company added most to Comcast in Q3 2019, an estimated $1.53M increase.
  • Van Leeuwen & Company's biggest Q3 2019 reduction was Bristol-Myers Squibb, cutting an estimated $1.57M.
  • Van Leeuwen & Company fully exited Pfizer in Q3 2019, selling an estimated $1.88M.
  • Van Leeuwen & Company's ten largest holdings make up 35% of its $106M portfolio in Q3 2019.
  • Van Leeuwen & Company opened 8 new positions and closed 11 in Q3 2019.
  • Van Leeuwen & Company's portfolio value fell 4.9% quarter-over-quarter to $106M.

Based on Van Leeuwen & Company's 13F filing for Q3 2019, filed 12 Nov 2019.